Integra Lifesciences (NASDAQ:IART) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Integra Lifesciences beat estimated earnings by 8.82%, reporting an EPS of $0.74 versus an estimate of $0.68.
Revenue was up $16.57 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 1.98% increase in the share price the next day.
Here's a look at Integra Lifesciences's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.83 | 0.72 | 0.66 | 0.57 |
| EPS Actual | 0.84 | 0.86 | 0.79 | 0.69 |
| Revenue Estimate | 403.40M | 384.58M | 376.01M | 349.81M |
| Revenue Actual | 405.52M | 386.86M | 389.99M | 360.07M |
To track all earnings releases for Integra Lifesciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
